Ask AI
Overcoming Obstacles in Obesity

CE / CME

Breaking Barriers in Obesity Care: Applying Emerging Evidence to Primary Care Practice

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

ABIM MOC: maximum of 1.00 Medical Knowledge MOC point

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

Released: December 10, 2025

Expiration: December 09, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Your patient has obesity and multiple cardiometabolic risk factors. Their primary goal is reducing cardiometabolic risk, and they would like to know which metrics are best for assessing this. How would you advise them?

2.

Your patient is considering an incretin-based therapy for obesity management. They have cardiovascular (CV) risk factors but no established cardiovascular disease (CVD). They’d like to know whether an incretin-based therapy could help prevent CV events. What would you tell them?

3.

Your patient is receiving tirzepatide 10 mg/wk for obesity management and treatment of obstructive sleep apnea (OSA). After 1 yr, they have met their weight loss goal of 10% and experienced some OSA improvement. You have discussed increasing the dose to 15 mg/wk because it is associated with greater weight loss in more people. Your patient wants to know if this would also help with their OSA. What do you tell them?